Edward Kwan

574 total citations
20 papers, 337 citations indexed

About

Edward Kwan is a scholar working on Public Health, Environmental and Occupational Health, Hematology and Surgery. According to data from OpenAlex, Edward Kwan has authored 20 papers receiving a total of 337 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Public Health, Environmental and Occupational Health, 7 papers in Hematology and 4 papers in Surgery. Recurrent topics in Edward Kwan's work include Acute Lymphoblastic Leukemia research (10 papers), Acute Myeloid Leukemia Research (4 papers) and Childhood Cancer Survivors' Quality of Life (4 papers). Edward Kwan is often cited by papers focused on Acute Lymphoblastic Leukemia research (10 papers), Acute Myeloid Leukemia Research (4 papers) and Childhood Cancer Survivors' Quality of Life (4 papers). Edward Kwan collaborates with scholars based in Australia, United States and Canada. Edward Kwan's co-authors include Michelle Haber, Murray D. Norris, Glenn M. Marshall, William A. Shucart, Luciano Dalla Pozza, Barbara Stewart, Janice Madafiglio, Andrei V. Gudkov, Eugene Mechetner and G M Marshall and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

Edward Kwan

20 papers receiving 321 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edward Kwan Australia 10 213 132 87 79 60 20 337
Ci Pan China 14 157 0.7× 96 0.7× 107 1.2× 109 1.4× 55 0.9× 37 405
WA Kamps Netherlands 7 271 1.3× 207 1.6× 67 0.8× 123 1.6× 86 1.4× 11 394
Henrik Schr�der Denmark 8 234 1.1× 151 1.1× 57 0.7× 98 1.2× 24 0.4× 13 371
Sharon Bergeron United States 8 152 0.7× 57 0.4× 71 0.8× 80 1.0× 98 1.6× 10 291
Kensuke Kondoh Japan 10 200 0.9× 68 0.5× 77 0.9× 144 1.8× 16 0.3× 23 358
Cristina N. Alonso Argentina 11 194 0.9× 165 1.3× 74 0.9× 71 0.9× 61 1.0× 30 384
April Sorrell United States 9 201 0.9× 314 2.4× 90 1.0× 71 0.9× 29 0.5× 18 498
Elva Jiménez‐Hernández Mexico 10 105 0.5× 79 0.6× 95 1.1× 68 0.9× 27 0.5× 33 312
Eric S. Schafer United States 11 200 0.9× 95 0.7× 92 1.1× 159 2.0× 48 0.8× 36 391
E R van Wering Netherlands 11 246 1.2× 284 2.2× 68 0.8× 72 0.9× 43 0.7× 14 467

Countries citing papers authored by Edward Kwan

Since Specialization
Citations

This map shows the geographic impact of Edward Kwan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward Kwan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward Kwan more than expected).

Fields of papers citing papers by Edward Kwan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward Kwan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward Kwan. The network helps show where Edward Kwan may publish in the future.

Co-authorship network of co-authors of Edward Kwan

This figure shows the co-authorship network connecting the top 25 collaborators of Edward Kwan. A scholar is included among the top collaborators of Edward Kwan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward Kwan. Edward Kwan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mulley, William R., Kevan R. Polkinghorne, Greg H. Tesch, et al.. (2025). A randomized controlled trial of intravenous immunoglobulin vs standard of care for the treatment of chronic active antibody-mediated rejection in kidney transplant recipients. Kidney International. 108(3). 470–480. 1 indexed citations
2.
Lee, Eric, et al.. (2025). Couple-Based Carrier Screening: How Gene and Variant Considerations Impact Outcomes. Genes. 16(6). 671–671. 1 indexed citations
4.
Kwan, Edward, et al.. (2022). Accurate lesion localisation facilitates nephron sparing surgery in reninoma patients: case report and discussion. Urology Case Reports. 43. 102069–102069. 1 indexed citations
5.
Kwan, Edward, et al.. (2022). Cytoreductive Surgery for Primary Central Nervous System Lymphoma: Is it time to consider extent of resection?. Journal of Clinical Neuroscience. 106. 110–116. 2 indexed citations
6.
Kwan, Edward, et al.. (2020). Intestinal adenomyoma – An unusual cause of intussusception in an infant. Pathology. 52. S79–S79. 1 indexed citations
7.
Bell, Christopher G., et al.. (2009). Molecular confirmation of pathological specimen integrity in Australasia. Pathology. 41(3). 280–283. 4 indexed citations
8.
Henderson, Michelle J., Edward Kwan, Alex H. Beesley, et al.. (2007). Relapse in children with acute lymphoblastic leukemia involving selection of a preexisting drug-resistant subclone. Blood. 110(2). 632–639. 72 indexed citations
9.
Laughton, Stephen, Lesley J. Ashton, Edward Kwan, et al.. (2005). Early Responses to Chemotherapy of Normal and Malignant Hematologic Cells Are Prognostic in Children With Acute Lymphoblastic Leukemia. Journal of Clinical Oncology. 23(10). 2264–2271. 25 indexed citations
10.
Marshall, Glenn M., Michelle Haber, Edward Kwan, et al.. (2003). Importance of Minimal Residual Disease Testing During the Second Year of Therapy for Children With Acute Lymphoblastic Leukemia. Journal of Clinical Oncology. 21(4). 704–709. 37 indexed citations
11.
Kwan, Edward, et al.. (2001). Detection of minimal residual disease in peripheral blood prior to clinical relapse of childhood acute lymphoblastic leukaemia using PCR. Molecular and Cellular Probes. 15(2). 99–103. 5 indexed citations
12.
Kwan, Edward, et al.. (2000). Simultaneous detection and quantification of minimal residual disease in childhood acute lymphoblastic leukaemia using real‐time polymerase chain reaction. British Journal of Haematology. 109(2). 430–434. 13 indexed citations
13.
Kwan, Edward, Lei Zhou, V. Tobias, et al.. (1998). Molecular detection of acute lymphoblastic leukaemia in boys with testicular relapse.. Molecular Pathology. 51(5). 277–281. 10 indexed citations
14.
Haber, Michelle, Edward Kwan, Ling Zhu, G M Marshall, & Murray D. Norris. (1997). Sensitive non‐radioactive PCR detection of clonal T‐cell receptor‐gamma gene rearrangements in childhood acute lymphoblastic leukaemia. British Journal of Haematology. 98(4). 995–998. 4 indexed citations
15.
Norris, Murray D., David de Graaf, Michelle Haber, et al.. (1996). Involvement ofMDR1 P-glycoprotein in multifactorial resistance to methotrexate. International Journal of Cancer. 65(5). 613–619. 70 indexed citations
16.
Norris, Murray D., David de Graaf, Michelle Haber, et al.. (1996). Involvement of MDR1 P‐glycoprotein in multifactorial resistance to methotrexate. International Journal of Cancer. 65(5). 613–619. 2 indexed citations
17.
Norris, Murray D., Edward Kwan, Michelle Haber, & G M Marshall. (1995). Detection of evolving immunoglobulin heavy-chain gene rearrangements in acute lymphoblastic leukemia: a PCR-based assay employing overlapping DJH primers.. PubMed. 9(10). 1779–82. 14 indexed citations
18.
Kwan, Edward, Michelle Haber, MJ Brisco, et al.. (1995). Characterization of clonal immunoglobulin heavy chain and I cell receptor gamma gene rearrangements during progression of childhood acute lymphoblastic leukemia.. PubMed. 9(11). 1847–50. 27 indexed citations
19.
Shucart, William A., et al.. (1987). Intradural Spinal Lipomas. Neurosurgery. 21(3). 343–346. 35 indexed citations
20.
Shannon, Kevin, et al.. (1984). T cell-derived glucosteroid response-modifying factor (GRMFT): a unique lymphokine made by normal T lymphocytes and a T cell hybridoma.. The Journal of Immunology. 132(2). 821–827. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026